CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences (Nasdaq:HLCS), a life science company focused on innovative genetic analysis technologies, today announced its support for the “1000 Genomes Project.” The international consortium’s vision of moving the collective knowledge of the human genome forward is an important step toward the goal of personalized medicine.
